Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS DiseasesRita Raddatz, Robert L. Hudkins, Ming Tao|Current Topics in Medicinal Chemistry|2010Cited by 74
Discovery and Characterization of 6-{4-[3-(<i>R</i>)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2<i>H</i>-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H<sub>3</sub>Receptor Inverse AgonistRobert L. Hudkins, Michael Williams, Ming Tao et al.|Journal of Medicinal Chemistry|2011Cited by 68
CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting ActivitiesRita Raddatz, Michael Williams, John P. Mallamo et al.|Journal of Pharmacology and Experimental Therapeutics|2011Cited by 58
Chapter 4 Recent Advances in Drug Discovery of Histamine H3 AntagonistsRobert L. Hudkins, Rita Raddatz|Annual reports in medicinal chemistry|2007Cited by 41